DYNE THERAPEUTICS INC shareholders Q3 2023

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.

DYNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
China Universal Asset Management Co., Ltd. 1,558$140.00%
B. Metzler seel. Sohn & Co. AG 18,973$169,9980.00%
GOLDMAN SACHS GROUP INC 1,508,142$13,512,9520.00%
DIMENSIONAL FUND ADVISORS LP 943,208$8,450,6950.00%
NEW YORK LIFE INVESTMENT MANAGEMENT LLC 30,906$276,9180.00%
Russell Investments Group, Ltd. 147,146$1,318,4260.00%
Tower Research Capital LLC (TRC) 7,989$71,5820.00%
MetLife Investment Management, LLC 22,933$205,4800.00%
GROUP ONE TRADING, L.P. 60,334$540,5930.00%
Truvestments Capital LLC 464$4,1570.00%
Walleye Trading LLC 24,326$217,9610.00%
AMERICAN INTERNATIONAL GROUP, INC. 21,212$190,0600.00%
BlackRock Inc. 3,306,965$29,630,4070.00%
FMR LLC 846,360$7,583,3860.00%
TWO SIGMA INVESTMENTS, LP 24,400$218,6240.00%
VANGUARD GROUP INC 2,364,314$21,184,2530.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 325,371$2,915,3240.00%
PUTNAM INVESTMENTS LLC 36,737$329,1640.00%
STATE STREET CORP 1,938,642$17,370,2320.00%
RHUMBLINE ADVISERS 70,571$632,3050.00%
External links

This page lists DYNE THERAPEUTICS INC's shareholders in Q3 2023. To view DYNE THERAPEUTICS INC's shareholder history, click here.